Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal betamethasone for prevention of neonatal respiratory distress syndrome in multifetal pregnancies
IRCT20180227038879N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of betamethasone in respiratory distress syndrome (RDS) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Neonatal respiratory distress syndrome. Started Feb 2018; status: completed.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20180227038879N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180227038879N1.